Skip to content
PICO PortalSearch builder

From a question

In adults with type 2 diabetes, are GLP-1 receptor agonists associated with a lower risk of dementia or cognitive decline compared with other glucose-lowering drugs?

DoneStarted Oct 28, 2026, 17:59 UTCFinished Oct 28, 2026, 18:02 UTCVersion 2

Stages

  1. Finding the known studies(done)
  2. Drafting(done)
  3. Checking MeSH(done)
  4. Counting in PubMed(done)
  5. Checking known studies(done)
  6. Comparing with the reference(done)
  7. Run Search(done)
  8. Saving(done)
Run log (20)
  1. Finding the known studies: No known studies were given
  2. Drafting: Drafting concepts and terms
  3. Checking MeSH: Checking every MeSH heading, Supplementary Concept and publication type against NLM
  4. Counting in PubMed: Running 13 lines on PubMed
  5. Line 2: 247,825 records
  6. Line 3: 297,627 records
  7. Line 4: 23,330 records
  8. Line 6: 42,071 records
  9. Line 7: 482,263 records
  10. Line 8: 1,068,413 records
  11. Line 10: 752 records
  12. Line 1: 204,451 records
  13. Line 11: 4,884,955 records
  14. Line 12: 725 records
  15. Line 13: 709 records
  16. Line 9: 1,156,402 records
  17. Line 5: 40,424 records
  18. Run Search: Fetching the first 20 records
  19. Saving: Saving the run
  20. Finished.

Final count (line 13)

709

Open in PubMed (opens in a new tab)
Query as run (1,398 characters)(((("Diabetes Mellitus, Type 2"[Mesh:NoExp]) OR ("type 2 diabetes"[tiab] OR "type II diabetes"[tiab] OR "diabetes mellitus type 2"[tiab] OR T2DM[tiab] OR T2D[tiab] OR "non-insulin-dependent diabetes"[tiab] OR NIDDM[tiab] OR "adult onset diabetes"[tiab])) AND (("Glucagon-Like Peptide-1 Receptor Agonists"[Mesh] OR "Glucagon-Like Peptide-1 Receptor"[Mesh] OR "Glucagon-Like Peptide 1"[Mesh] OR "Liraglutide"[Mesh] OR "Exenatide"[Mesh] OR "Semaglutide"[Mesh] OR "dulaglutide"[Supplementary Concept] OR "lixisenatide"[Supplementary Concept] OR "Tirzepatide"[Mesh]) OR ("glucagon-like peptide-1"[tiab] OR "GLP-1"[tiab] OR "GLP-1RA"[tiab] OR "GLP-1RAs"[tiab] OR GLP1RA[tiab] OR GLP1RAs[tiab] OR "incretin mimetic*"[tiab] OR "incretin-based"[tiab] OR liraglutide[tiab] OR semaglutide[tiab] OR dulaglutide[tiab] OR exenatide[tiab] OR lixisenatide[tiab] OR albiglutide[tiab] OR tirzepatide[tiab] OR efpeglenatide[tiab])) AND (("Dementia"[Mesh] OR "Cognitive Dysfunction"[Mesh] OR "Cognition Disorders"[Mesh] OR "Memory Disorders"[Mesh] OR "Cognition"[Mesh:NoExp]) OR (dement*[tiab] OR Alzheimer*[tiab] OR cognit*[tiab] OR "memory impairment"[tiab] OR "memory loss"[tiab] OR "memory decline"[tiab] OR neurodegenerat*[tiab]))) NOT ("Comment"[Publication Type] OR "Editorial"[Publication Type] OR "Letter"[Publication Type] OR "Case Reports"[Publication Type] OR "Preprint"[Publication Type])) AND english[la]

Known studies

No known studies were given, so recall was not checked.

Only studies the model never saw are counted. Finding known studies does not prove the search is complete.

Reference strategy

No reference strategy was given.

Search lines

Vocabulary terms are marked ✓︎ valid, ↪︎ mapped to the preferred heading, ✗︎ not found, ⚠︎ not checked.
Numbered search lines with their PubMed counts
No.SearchResults
1

Type 2 diabetes

"Diabetes Mellitus, Type 2"[Mesh:NoExp] (MeSH heading valid: D003924)		204,262
2

Type 2 diabetes

"type 2 diabetes"[tiab] OR "type II diabetes"[tiab] OR "diabetes mellitus type 2"[tiab] OR T2DM[tiab] OR T2D[tiab] OR "non-insulin-dependent diabetes"[tiab] OR NIDDM[tiab] OR "adult onset diabetes"[tiab]		247,825
3

Type 2 diabetes · block

1 OR 2		297,442
4

GLP-1 receptor agonists

"Glucagon-Like Peptide-1 Receptor Agonists"[Mesh] (MeSH heading valid: D000097789) OR "Glucagon-Like Peptide-1 Receptor"[Mesh] (MeSH heading valid: D000067757) OR "Glucagon-Like Peptide 1"[Mesh] (MeSH heading valid: D052216) OR "Liraglutide"[Mesh] (MeSH heading valid: D000069450) OR "Exenatide"[Mesh] (MeSH heading valid: D000077270) OR "Semaglutide"[Mesh] (MeSH heading valid: D000099194) OR "dulaglutide"[Supplementary Concept] (Supplementary Concept valid: C555680) OR "lixisenatide"[Supplementary Concept] (Supplementary Concept valid: C479460) OR "Tirzepatide"[Mesh] (MeSH heading valid: D000098860)		23,330
5

GLP-1 receptor agonists

"glucagon-like peptide-1"[tiab] OR "GLP-1"[tiab] OR "GLP-1RA"[tiab] OR "GLP-1RAs"[tiab] OR GLP1RA[tiab] OR GLP1RAs[tiab] OR "incretin mimetic*"[tiab] OR "incretin-based"[tiab] OR liraglutide[tiab] OR semaglutide[tiab] OR dulaglutide[tiab] OR exenatide[tiab] OR lixisenatide[tiab] OR albiglutide[tiab] OR tirzepatide[tiab] OR efpeglenatide[tiab]		40,424
6

GLP-1 receptor agonists · block

4 OR 5		42,071
7

Dementia and cognitive decline

"Dementia"[Mesh] (MeSH heading valid: D003704) OR "Cognitive Dysfunction"[Mesh] (MeSH heading valid: D060825) OR "Cognition Disorders"[Mesh] (MeSH heading valid: D003072) OR "Memory Disorders"[Mesh] (MeSH heading valid: D008569) OR "Cognition"[Mesh:NoExp] (MeSH heading valid: D003071)		482,263
8

Dementia and cognitive decline

dement*[tiab] OR Alzheimer*[tiab] OR cognit*[tiab] OR "memory impairment"[tiab] OR "memory loss"[tiab] OR "memory decline"[tiab] OR neurodegenerat*[tiab]		1,068,413
9

Dementia and cognitive decline · block

7 OR 8		1,156,402
10

combined

3 AND 6 AND 9		752
11

excluded

"Comment"[Publication Type] (publication type valid: D016420) OR "Editorial"[Publication Type] (publication type valid: D016421) OR "Letter"[Publication Type] (publication type valid: D016422) OR "Case Reports"[Publication Type] (publication type valid: D002363) OR "Preprint"[Publication Type] (publication type valid: D000076942)		4,884,955
12

exclusions removed

10 NOT 11		725
13Final

limits

12 AND english[la]		709

Issues

1 errors, 2 warnings, 0 notes
  • Error: "albiglutide" is not a Supplementary Concept. Kept as a disabled text term.
  • Warning: Language limit (english): it can remove relevant studies; report and justify it.
  • Warning: Publication types excluded with NOT (Comment, Editorial, Letter, Case Reports, Preprint): report and justify the exclusion.

First records

The first 20 of the final line's records, as PubMed sorts them.
  1. Impact of GLP-1 Receptor Agonists on Cognitive Performance in Adults at Risk of Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. (PubMed, opens in a new tab)

    Abbatecola AM, Migliara G, D'Agostino F et al. · Nutrients · 2026 · PMID 42942883

  2. Neuropsychiatric Outcomes Associated With GLP-1 Receptor Agonist Use in Medicare Beneficiaries With Type 2 Diabetes: Variation by Treatment Pattern and Obesity Status. (PubMed, opens in a new tab)

    Baik SH, Baye F, Xian H et al. · Diabetes, obesity & metabolism · 2026 · PMID 42928425

  3. Modern antidiabetic therapy in older adults with type 2 diabetes: evidence, best practice and a clinical pharmacist's framework. (PubMed, opens in a new tab)

    Martinc B, Šabovič M, Janić M et al. · Expert review of clinical pharmacology · 2026 · PMID 42911774

  4. Diabetes-Associated Cognitive Dysfunction: Pathophysiology, Molecular Mechanisms, and Emerging Therapeutic Strategies. (PubMed, opens in a new tab)

    Sarkar R, Kabra A, S Saeedan A et al. · ACS pharmacology & translational science · 2026 · PMID 42871641

  5. The effects of improved access to diabetes medications on risk of Alzheimer's disease and related dementias. (PubMed, opens in a new tab)

    Barthold D, Zissimopoulos J, Basu A et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026 · PMID 42860380

  6. GLP-1 receptor agonists in perimenopause and early postmenopause: clinical role, cardiometabolic benefits and knowledge gaps. (PubMed, opens in a new tab)

    Ozcivit Erkan IB, Senturk LM, Erel CT et al. · Climacteric : the journal of the International Menopause Society · 2026 · PMID 42847987

  7. GLP-1 Receptor Agonists Versus DPP-4 Inhibitors and Incident Dementia Risk in COVID-19 Survivors with Type 2 Diabetes: A Target Trial Emulation Study. (PubMed, opens in a new tab)

    Hung KC, Yu TS, Liu PH et al. · Drug design, development and therapy · 2026 · PMID 42831108

  8. Mitohormesis linking metabolic dysfunction and neurodegeneration: implications for dementia and therapeutic strategies. (PubMed, opens in a new tab)

    Otoda T, Nakajima H, Takayama T · Frontiers in molecular neuroscience · 2026 · PMID 42812893

  9. Genetic Insights Into Protective Effects of GLP-1 Receptor Agonists on Stroke and Alzheimer Disease Across Ancestries. (PubMed, opens in a new tab)

    Caro-Châtelier I, Sargurupremraj M, Yang C et al. · Neurology. Genetics · 2026 · PMID 42812740

  10. Benefits of sodium-glucose cotransporter 2 inhibitors versus glucagon-like peptide-1 receptor agonists in older patients with type 2 diabetes. (PubMed, opens in a new tab)

    Mortada I, Paul K, Rice J et al. · Diabetes & vascular disease research · 2026 · PMID 42808164

  11. Trajectory-Oriented Brain Vulnerability Framework for Cognitive Decline in Type 2 Diabetes. (PubMed, opens in a new tab)

    Komel J, Klen J · International journal of molecular sciences · 2026 · PMID 42794768

  12. The Interplay of Metabolic Dysfunction, Neuroinflammation, and Mitochondrial Dysfunction in Balance Impairment: Insights from Type 2 Diabetes Mellitus and Alzheimer's Disease. (PubMed, opens in a new tab)

    Fakorede S, Lateef OM, Udefa AL et al. · Molecular neurobiology · 2026 · PMID 42789205

  13. Evoke (+) trials of semaglutide for early alzheimer's disease: Innovations, lessons, and implications. (PubMed, opens in a new tab)

    Cummings JL, Scheltens P · The journal of prevention of Alzheimer's disease · 2026 · PMID 42785112

  14. The Intertwined Threat: How Diabetes Impacts Neurological Disorders - A Review Article. (PubMed, opens in a new tab)

    Rajput P, Jakhar M, Kashyap A et al. · Acta neurologica Taiwanica · 2026 · PMID 42784708

  15. Dementia progression with GLP-1 receptor agonists in people with mild cognitive impairment and type 2 diabetes: target-trial emulation study. (PubMed, opens in a new tab)

    Schechter M, Sehtman-Shachar DR, Fishkin A et al. · Alzheimer's & dementia (New York, N. Y.) · 2026 · PMID 42769274

  16. Comparative Risk of Nonarteritic Anterior Ischemic Optic Neuropathy Among Glucagon-Like Peptide-1 Receptor Agonists: An Integrated Safety and Mechanistic Analysis. (PubMed, opens in a new tab)

    Sun H, Xin X, Yan J et al. · Diabetes, obesity & metabolism · 2026 · PMID 42768849

  17. Glucagon-like peptide-1 receptor agonists and cognitive function: beyond the metabolic effects. (PubMed, opens in a new tab)

    Polyzos SA, Doulberis M, Zervogiannis N et al. · Hormones (Athens, Greece) · 2026 · PMID 42736531

  18. Glycolytic Reprogramming in Parkinson's Disease: From Bioenergetic Crosstalk to Therapeutic Modulation. (PubMed, opens in a new tab)

    Yi Y, Chen C, He Y et al. · Medicinal research reviews · 2026 · PMID 42695230

  19. The Crosstalk Between Diabetes and Alzheimer's Disease: A Molecular Perspective. (PubMed, opens in a new tab)

    Catakli D, Ozen-Basoglu O, Tuncgovde EB et al. · Basic & clinical pharmacology & toxicology · 2026 · PMID 42693696

  20. Shared Metabolic-Proteinopathy Axis in Alzheimer's Disease and Parkinson's Disease: Evidence for a Convergent but Not Identical Disease Spectrum. (PubMed, opens in a new tab)

    Yao SY, Du MQ, Lin LX et al. · Aging medicine (Milton (N.S.W)) · 2026 · PMID 42688951

Export

Strategy (.txt)PMIDs (.txt)MEDLINE (.txt)Provenance (.json)

The strategy file has the numbered lines with counts, the search date and the AI-use statement. PMIDs and MEDLINE are fetched from PubMed when you download, so they reflect PubMed today.

Checking PubMed for the current list of PMIDs…

Objective and notes from the draft

To determine whether, in adults with type 2 diabetes, treatment with glucagon-like peptide-1 (GLP-1) receptor agonists is associated with a lower risk of incident dementia or cognitive decline than treatment with other glucose-lowering drugs.

  • The comparator (other glucose-lowering drugs) is not searched as a separate concept, so that studies comparing with placebo, with any active drug, or reporting class comparisons only in the full text are not missed.
  • Tirzepatide, a dual GIP/GLP-1 receptor agonist, is included because it is often grouped with the class; remove it if the review is limited to selective GLP-1 receptor agonists.
  • Parkinson disease and other non-dementia neurodegenerative outcomes are not searched as headings; the neurodegenerat* text word may retrieve some of these studies, which can be screened out.
  • The truncated term cognit* is deliberately broad within the outcome block; it is combined with the diabetes and GLP-1 blocks, which keeps the final result set manageable.
  • The diabetes block is required; studies of GLP-1 receptor agonists in mixed populations that mention type 2 diabetes only in the full text could be missed, so consider screening the GLP-1 AND dementia combination without the diabetes block if the result set allows.

Edit the strategy

Changes are not searched until you recount. Each recount is saved as a new version.

Type 2 diabetesPopulation

297,442 records · 9 of 9 terms on · 4 suggestions off

  • MeSH valid: D003924AI

    "Diabetes Mellitus, Type 2"[Mesh:NoExp]

    Specific heading for the review population; its narrower headings are all forms of type 2 diabetes.

  • TextAI

    "type 2 diabetes"[tiab]

    Most common author wording; also matches type 2 diabetes mellitus.

    Fields to search for type 2 diabetes
  • TextAI

    "type II diabetes"[tiab]

    Roman-numeral spelling variant.

    Fields to search for type II diabetes
  • TextAI

    "diabetes mellitus type 2"[tiab]

    Inverted word order used by some authors and registries.

    Fields to search for diabetes mellitus type 2
  • TextAI

    T2DM[tiab]

    Standard abbreviation, often used alone in abstracts.

    Fields to search for T2DM
  • TextAI

    T2D[tiab]

    Shorter abbreviation used in epidemiological studies.

    Fields to search for T2D
  • TextAI

    "non-insulin-dependent diabetes"[tiab]

    Older entry-term synonym of the heading.

    Fields to search for non-insulin-dependent diabetes
  • TextAI

    NIDDM[tiab]

    Abbreviation of the older synonym.

    Fields to search for NIDDM
  • TextAI

    "adult onset diabetes"[tiab]

    Older entry-term synonym of the heading.

    Fields to search for adult onset diabetes
Suggested MeSH entry terms (4, off)
  • TextEntry term

    "Maturity-Onset Diabetes"[tiab]

    Synonym of the MeSH heading "Diabetes Mellitus, Type 2" (D003924)

    Fields to search for Maturity-Onset Diabetes
  • TextEntry term

    "Maturity-Onset Diabetes Mellitus"[tiab]

    Synonym of the MeSH heading "Diabetes Mellitus, Type 2" (D003924)

    Fields to search for Maturity-Onset Diabetes Mellitus
  • TextEntry term

    "Noninsulin-Dependent Diabetes Mellitus"[tiab]

    Synonym of the MeSH heading "Diabetes Mellitus, Type 2" (D003924)

    Fields to search for Noninsulin-Dependent Diabetes Mellitus
  • TextEntry term

    "MODY Maturity-onset diabetes of the young"[tiab]

    Synonym of the MeSH heading "Diabetes Mellitus, Type 2" (D003924)

    Fields to search for MODY (Maturity-onset diabetes of the young)
Fields to search

GLP-1 receptor agonistsIntervention

42,071 records · 25 of 26 terms on · 20 suggestions off

  • MeSH valid: D000097789AI

    "Glucagon-Like Peptide-1 Receptor Agonists"[Mesh]

    Pharmacological-action heading for the drug class under review.

  • MeSH valid: D000067757AI

    "Glucagon-Like Peptide-1 Receptor"[Mesh]

    Receptor heading often assigned to studies of agonists indexed before the drug-class heading existed.

  • MeSH valid: D052216AI

    "Glucagon-Like Peptide 1"[Mesh]

    Hormone heading used for GLP-1 analogues in older indexing.

  • MeSH valid: D000069450AI

    "Liraglutide"[Mesh]

    Heading for a widely studied GLP-1 receptor agonist.

  • MeSH valid: D000077270AI

    "Exenatide"[Mesh]

    Heading for the first marketed GLP-1 receptor agonist.

  • MeSH valid: D000099194AI

    "Semaglutide"[Mesh]

    Supplementary Concept for semaglutide, a major agent in recent cohort studies and trials.

  • SCR valid: C555680AI

    "dulaglutide"[Supplementary Concept]

    Supplementary Concept for dulaglutide, studied in the REWIND cognitive analyses.

  • SCR valid: C479460AI

    "lixisenatide"[Supplementary Concept]

    Supplementary Concept for lixisenatide.

  • TextAI

    albiglutide[tiab]

    proposed as a Supplementary Concept; no such record

    Fields to search for albiglutide
    • Error: "albiglutide" is not a Supplementary Concept. Kept as a disabled text term.
  • MeSH valid: D000098860AI

    "Tirzepatide"[Mesh]

    Supplementary Concept for the dual GIP/GLP-1 receptor agonist, often grouped with the class.

  • TextAI

    "glucagon-like peptide-1"[tiab]

    Full name of the hormone; covers receptor agonist and analogue phrasing.

    Fields to search for glucagon-like peptide-1
  • TextAI

    "GLP-1"[tiab]

    Standard abbreviation; also matches GLP1 and GLP-1 RA phrasings.

    Fields to search for GLP-1
  • TextAI

    "GLP-1RA"[tiab]

    Joined abbreviation not matched by the GLP-1 phrase.

    Fields to search for GLP-1RA
  • TextAI

    "GLP-1RAs"[tiab]

    Plural of the joined abbreviation, listed because the stem is too short to truncate.

    Fields to search for GLP-1RAs
  • TextAI

    GLP1RA[tiab]

    Fully joined abbreviation variant.

    Fields to search for GLP1RA
  • TextAI

    GLP1RAs[tiab]

    Plural of the fully joined abbreviation.

    Fields to search for GLP1RAs
  • TextAI

    "incretin mimetic*"[tiab]

    Older class name for GLP-1 receptor agonists.

    Fields to search for incretin mimetic
  • TextAI

    "incretin-based"[tiab]

    Term used for incretin-based therapies that include GLP-1 receptor agonists.

    Fields to search for incretin-based
  • TextAI

    liraglutide[tiab]

    Drug name for records not yet indexed.

    Fields to search for liraglutide
  • TextAI

    semaglutide[tiab]

    Drug name for records not yet indexed.

    Fields to search for semaglutide
  • TextAI

    dulaglutide[tiab]

    Drug name for records not yet indexed.

    Fields to search for dulaglutide
  • TextAI

    exenatide[tiab]

    Drug name for records not yet indexed.

    Fields to search for exenatide
  • TextAI

    lixisenatide[tiab]

    Drug name for records not yet indexed.

    Fields to search for lixisenatide
  • TextAI

    albiglutide[tiab]

    Drug name for records not yet indexed.

    Fields to search for albiglutide
  • TextAI

    tirzepatide[tiab]

    Dual agonist name for records not yet indexed.

    Fields to search for tirzepatide
  • TextAI

    efpeglenatide[tiab]

    Investigational long-acting GLP-1 receptor agonist studied in outcome trials.

    Fields to search for efpeglenatide
Suggested MeSH entry terms (20, off)
  • TextEntry term

    "GLP1 Agonists"[tiab]

    Synonym of the MeSH heading "Glucagon-Like Peptide-1 Receptor Agonists" (D000097789)

    Fields to search for GLP1 Agonists
  • TextEntry term

    "GLP1R Agonists"[tiab]

    Synonym of the MeSH heading "Glucagon-Like Peptide-1 Receptor Agonists" (D000097789)

    Fields to search for GLP1R Agonists
  • TextEntry term

    "GLP-1R Agonists"[tiab]

    Synonym of the MeSH heading "Glucagon-Like Peptide-1 Receptor Agonists" (D000097789)

    Fields to search for GLP-1R Agonists
  • TextEntry term

    "GLP1R Protein"[tiab]

    Synonym of the MeSH heading "Glucagon-Like Peptide-1 Receptor" (D000067757)

    Fields to search for GLP1R Protein
  • TextEntry term

    "GLP1R Receptor"[tiab]

    Synonym of the MeSH heading "Glucagon-Like Peptide-1 Receptor" (D000067757)

    Fields to search for GLP1R Receptor
  • TextEntry term

    "GLP-1R Receptor"[tiab]

    Synonym of the MeSH heading "Glucagon-Like Peptide-1 Receptor" (D000067757)

    Fields to search for GLP-1R Receptor
  • TextEntry term

    "NN-2211"[tiab]

    Narrower concept "NN 2211" under the MeSH heading "Liraglutide" (D000069450)

    Fields to search for NN-2211
  • TextEntry term

    Saxenda[tiab]

    Narrower concept under the MeSH heading "Liraglutide" (D000069450)

    Fields to search for Saxenda
  • TextEntry term

    Victoza[tiab]

    Narrower concept under the MeSH heading "Liraglutide" (D000069450)

    Fields to search for Victoza
  • TextEntry term

    NN2211[tiab]

    Narrower concept "NN 2211" under the MeSH heading "Liraglutide" (D000069450)

    Fields to search for NN2211
  • TextEntry term

    Byetta[tiab]

    Narrower concept under the MeSH heading "Exenatide" (D000077270)

    Fields to search for Byetta
  • TextEntry term

    "AC 2993"[tiab]

    Narrower concept under the MeSH heading "Exenatide" (D000077270)

    Fields to search for AC 2993
  • TextEntry term

    Bydureon[tiab]

    Narrower concept under the MeSH heading "Exenatide" (D000077270)

    Fields to search for Bydureon
  • TextEntry term

    "ITCA 650"[tiab]

    Narrower concept under the MeSH heading "Exenatide" (D000077270)

    Fields to search for ITCA 650
  • TextEntry term

    "AC 2993 LAR"[tiab]

    Narrower concept under the MeSH heading "Exenatide" (D000077270)

    Fields to search for AC 2993 LAR
  • TextEntry term

    Ozempic[tiab]

    Narrower concept under the MeSH heading "Semaglutide" (D000099194)

    Fields to search for Ozempic
  • TextEntry term

    Rybelsus[tiab]

    Narrower concept under the MeSH heading "Semaglutide" (D000099194)

    Fields to search for Rybelsus
  • TextEntry term

    Mounjaro[tiab]

    Narrower concept under the MeSH heading "Tirzepatide" (D000098860)

    Fields to search for Mounjaro
  • TextEntry term

    Zepbound[tiab]

    Narrower concept under the MeSH heading "Tirzepatide" (D000098860)

    Fields to search for Zepbound
  • TextEntry term

    LY3298176[tiab]

    Narrower concept under the MeSH heading "Tirzepatide" (D000098860)

    Fields to search for LY3298176
Fields to search

Dementia and cognitive declineOutcome

1,156,402 records · 12 of 12 terms on · 6 suggestions off

  • MeSH valid: D003704AI

    "Dementia"[Mesh]

    Explodes to Alzheimer disease, vascular dementia and other dementias, all of which are review outcomes.

  • MeSH valid: D060825AI

    "Cognitive Dysfunction"[Mesh]

    Heading for mild cognitive impairment and cognitive decline.

  • MeSH valid: D003072AI

    "Cognition Disorders"[Mesh]

    Broader heading for cognitive impairment indexed without a more specific term.

  • MeSH valid: D008569AI

    "Memory Disorders"[Mesh]

    Heading for memory impairment, a core feature of cognitive decline.

  • MeSH valid: D003071AI

    "Cognition"[Mesh:NoExp]

    Captures studies measuring cognitive function as an outcome; not exploded to avoid unrelated narrower headings.

  • TextAI

    dement*[tiab]

    Covers dementia, dementias and demented.

    Fields to search for dement
  • TextAI

    Alzheimer*[tiab]

    Covers Alzheimer, Alzheimer's and Alzheimers disease.

    Fields to search for Alzheimer
  • TextAI

    cognit*[tiab]

    Covers cognition, cognitive decline, cognitive impairment, cognitive function and neurocognitive outcomes in the abstract.

    Fields to search for cognit
  • TextAI

    "memory impairment"[tiab]

    Cognitive sense of memory, phrased to avoid immunological memory.

    Fields to search for memory impairment
  • TextAI

    "memory loss"[tiab]

    Lay and clinical wording for memory decline.

    Fields to search for memory loss
  • TextAI

    "memory decline"[tiab]

    Wording used in longitudinal cognitive studies.

    Fields to search for memory decline
  • TextAI

    neurodegenerat*[tiab]

    Captures studies framing dementia as neurodegenerative disease.

    Fields to search for neurodegenerat
Suggested MeSH entry terms (6, off)
  • TextEntry term

    Amentia[tiab]

    Synonym of the MeSH heading "Dementia" (D003704)

    Fields to search for Amentia
  • TextEntry term

    Overinclusion[tiab]

    Narrower concept under the MeSH heading "Cognition Disorders" (D003072)

    Fields to search for Overinclusion
  • TextEntry term

    "Spatial Memory Disorder"[tiab]

    Narrower concept "Memory Disorder, Spatial" under the MeSH heading "Memory Disorders" (D008569)

    Fields to search for Spatial Memory Disorder
  • TextEntry term

    "Semantic Memory Disorder"[tiab]

    Narrower concept "Memory Disorder, Semantic" under the MeSH heading "Memory Disorders" (D008569)

    Fields to search for Semantic Memory Disorder
  • TextEntry term

    "Age-Related Memory Disorders"[tiab]

    Narrower concept under the MeSH heading "Memory Disorders" (D008569)

    Fields to search for Age-Related Memory Disorders
  • TextEntry term

    "Memory Deficits"[tiab]

    Narrower concept under the MeSH heading "Memory Disorders" (D008569)

    Fields to search for Memory Deficits
Fields to search

Limits

Publication types to exclude

Each one is checked against MeSH publication types before it is added.

  • Comment
  • Editorial
  • Letter
  • Case Reports
  • Preprint

No changes.